Aberdeen Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Aberdeen Asset Management's AMGN Position: Q2 2017 in Review
Aberdeen Asset Management increased its Amgen (AMGN) stake by 5.5% in Q2 2017, buying an estimated $5.01M and bringing the position to 586,465 shares worth $101M. The position accounts for 0.34% of the portfolio, ranked #58.
Aberdeen Asset Management first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.
- Aberdeen Asset Management held 586,465 shares of Amgen worth $101M as of Q2 2017.
- Aberdeen Asset Management bought 30,827 Amgen shares in Q2 2017, an estimated $5.01M.
- Amgen made up 0.34% of Aberdeen Asset Management's portfolio in Q2 2017, its #58 holding.
- Aberdeen Asset Management first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
- 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.
Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.